RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-7.57%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.97B
AUM Growth
+$3.97B
(-8.2%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
30.63%
Holding
141
New
5
Increased
76
Reduced
8
Closed
5
Top Buys
| 1 |
DexCom
DXCM
|
$24.2M |
| 2 |
Idexx Laboratories
IDXX
|
$21.2M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$18.1M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$12.8M |
| 5 |
Penumbra
PEN
|
$12.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$18.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.6M |
| 3 |
Immuneering
IMRX
|
$17.6M |
| 4 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$13M |
| 5 |
XENT
Intersect ENT, Inc
XENT
|
$10.9M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Consumer Staples | 1.53% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
76
DELISTED
Verve Therapeutics
VERV
| $11.5M | 0.29% |
504,037
-398,889
| -44% | -$9.1M |
|
|
KDNY
77
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.5M | 0.29% |
700,349
-20,000
| -3% | -$327K |
|
|
AMYT
78
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $10.8M | 0.27% |
1,305,825
| – | – |
|
79
Fulcrum Therapeutics
FULC
$348M
| $10.3M | 0.26% |
434,590
-22,400
| -5% | -$530K |
|
|
OHPAU
80
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $9.82M | 0.25% |
1,000,000
| – | – |
|
81
Amicus Therapeutics
FOLD
$2.39B
| $9.59M | 0.24% |
1,012,506
| – | – |
|
82
Aurinia Pharmaceuticals
AUPH
$1.54B
| $9.55M | 0.24% |
771,018
+313,845
| +69% | +$3.89M |
|
|
LENZ
83
LENZ Therapeutics
LENZ
$1.11B
| $9.13M | 0.23% |
1,790,754
-288,156
| -14% | -$1.47M |
|
84
Akero Therapeutics
AKRO
$3.58B
| $9.01M | 0.23% |
635,214
+48,113
| +8% | +$683K |
|
|
GMDA
85
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $8.94M | 0.23% |
2,154,300
| – | – |
|
86
Spero Therapeutics
SPRO
$117M
| $8.62M | 0.22% |
990,913
+45,600
| +5% | +$397K |
|
87
Xilio Therapeutics
XLO
$37.1M
| $8.42M | 0.21% |
1,191,094
| – | – |
|
|
EPZM
88
DELISTED
Epizyme, Inc
EPZM
| $8.36M | 0.21% |
7,267,696
+3,460,034
| +91% | +$3.98M |
|
89
MacroGenics
MGNX
$118M
| $8.22M | 0.21% |
932,728
+75,523
| +9% | +$665K |
|
90
Athira Pharma
ATHA
$15.3M
| $7.46M | 0.19% |
552,252
| – | – |
|
|
FUSN
91
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $7.37M | 0.19% |
948,327
| – | – |
|
92
Compass Therapeutics
CMPX
$470M
| $7.3M | 0.18% |
5,328,088
| – | – |
|
93
Cullinan Oncology
CGEM
$443M
| $6.83M | 0.17% |
652,578
+6,500
| +1% | +$68.1K |
|
|
MREO
94
Mereo BioPharma
MREO
$277M
| $6.8M | 0.17% |
6,074,943
+489,322
| +9% | +$548K |
|
95
Leap Therapeutics
LPTX
$12.1M
| $6.29M | 0.16% |
3,595,447
+74,877
| +2% | +$131K |
|
|
EDAP
96
EDAP TMS
EDAP
$104M
| $5.95M | 0.15% |
820,000
+59,100
| +8% | +$428K |
|
97
Nkarta
NKTX
$150M
| $5.8M | 0.15% |
509,948
+2,700
| +0.5% | +$30.7K |
|
98
Design Therapeutics
DSGN
$335M
| $5.58M | 0.14% |
345,597
+10,350
| +3% | +$167K |
|
|
ICVX
99
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $5.36M | 0.13% |
761,557
+26,053
| +4% | +$183K |
|
100
Biomea Fusion
BMEA
$117M
| $5.2M | 0.13% |
1,165,582
| – | – |
|